Yubo International Biotech Limited
YBGJOTCHealthcare● Active
$0.01
+$0.00(+0.00%)
Market Cap$1006454
P/E Ratio—
52W High$0.1776
52W Low$0.0079
Yubo International Biotech Limited (YBGJ) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
YBGJ · earnings · updated Jun 15, 2026
Latest Earnings
Q2 FY2026Report Date: May 15, 2026EPS Actual
-$0.00
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 15, 2026
After Market Close
YBGJ reports quarterly as a OTC-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
79
days
Expected Date
Sep 2, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away79
Expected DateSep 2, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2026 | May 15, 2026 | — | -$0.00 | — | — | — | — |
| — Q1 FY2026 | Mar 31, 2026 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2025 | Nov 14, 2025 | — | -$0.00 | — | — | — | — |
| ◌ Q3 FY2025 | Aug 13, 2025 | — | — | — | — | — | — |
| ◌ Q2 FY2025 | May 14, 2025 | — | — | — | — | — | — |
| — Q4 FY2024 | Nov 13, 2024 | — | -$0.01 | — | — | — | — |
| ◌ Q3 FY2024 | Aug 19, 2024 | — | — | — | — | — | — |
| ◌ Q2 FY2024 | May 20, 2024 | — | — | — | — | — | — |
Q2 FY2026
May 15, 2026
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 31, 2026
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2025
Nov 14, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 13, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 14, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 13, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 19, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
May 20, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.53 | $1.53 | $1.53 | 1 |
| Q2 FY2024 | $1.33 | $1.33 | $1.33 | 1 |
| Q1 FY2024 | $1.57 | $1.57 | $1.57 | 1 |
| Q4 FY2023 | $2.09 | $2.09 | $2.09 | 1 |
| Q3 FY2023 | $1.39 | $1.39 | $1.39 | 1 |
| Q2 FY2023 | $1.19 | $1.19 | $1.19 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 15, 2026 | — | $0.01 | $0.01 | +0.00% |
| — Q1 FY2026 | Mar 31, 2026 | — | $0.02 | $0.02 | +0.00% |
| — Q4 FY2025 | Nov 14, 2025 | — | $0.01 | $0.01 | +0.00% |
| — Q4 FY2024 | Nov 13, 2024 | — | $0.12 | $0.13 | +16.96% |
| — Q3 FY2023 | Aug 11, 2023 | — | $0.54 | $0.54 | +0.00% |
| — Q2 FY2023 | May 15, 2023 | — | $0.09 | $0.09 | +0.00% |
| — Q2 FY2023 | Apr 14, 2023 | — | $0.09 | $0.09 | +0.00% |
| — Q4 FY2022 | Nov 16, 2022 | — | $0.14 | $0.14 | +0.00% |
Q2 FY2026+0.00%
Report Date
May 15, 2026
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q1 FY2026+0.00%
Report Date
Mar 31, 2026
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q4 FY2025+0.00%
Report Date
Nov 14, 2025
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q4 FY2024+16.96%
Report Date
Nov 13, 2024
EPS Beat/Miss
—
Price Before
$0.12
Price After
$0.13
Q3 FY2023+0.00%
Report Date
Aug 11, 2023
EPS Beat/Miss
—
Price Before
$0.54
Price After
$0.54
Q2 FY2023+0.00%
Report Date
May 15, 2023
EPS Beat/Miss
—
Price Before
$0.09
Price After
$0.09
Q2 FY2023+0.00%
Report Date
Apr 14, 2023
EPS Beat/Miss
—
Price Before
$0.09
Price After
$0.09
Q4 FY2022+0.00%
Report Date
Nov 16, 2022
EPS Beat/Miss
—
Price Before
$0.14
Price After
$0.14
Beat Rate0 / 8 quarters
Largest Move+16.96% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: YBGJ ends December
Yubo International Biotech Limited (YBGJ) most recently reported earnings on May 15, 2026 for Q2 FY2026, posting EPS of $-0.00 (in line with the analyst consensus of —). The next YBGJ earnings date is expected around September 2, 2026.
Each quarter, investors track YBGJ earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. YBGJ revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
YBGJ's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
YBGJ earnings · 4 questionsYubo International Biotech Limited's next earnings report is expected around September 2, 2026. YBGJ typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; YBGJ historically reports after market close (AMC).
YBGJ earnings datewhen is YBGJ earningsYBGJ next earnings datewhen does YBGJ report earningsYBGJ earnings calendar
▸ Source: FMP · Yubo International Biotech Limited SEC filings · US GAAP · Yubo International Biotech Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026